Julia Shklovskaya

  • Citations Per Year
Learn More
Objectives:Recent drug approvals have increased the availability of biologic therapies for inflammatory bowel disease (IBD), making it difficult for patients with ulcerative colitis (UC) and Crohn’s(More)
  • 1